Trial Profile
An Objective Assessment of Mealtime Bolus Insulin Behavior and Associated Factors
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 25 Sep 2020 Results presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
- 25 Sep 2020 Results evaluaitng differences between T1D and T2D participants regarding the association between hypoglycemic fear and missed bolus doses frequency, presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
- 26 Jul 2018 Status changed from active, no longer recruiting to completed.